跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Doptelet - NMPA Drug Approval Details
Approvals
/
NMPA
/
Avatrombopag Maleate tablet
Approved
化学药品
Avatrombopag Maleate tablet
Akarx, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Apr 14, 2020
Approval ID
7w10tmc2A32
Company
Akarx, Inc.
Type
化学药品
Approval Details
Approval Id
7w10tmc2A32
Approval Number
H20200005
Generic Name
马来酸阿伐曲泊帕片
Generic Name En
Avatrombopag Maleate tablet
Trade Name
苏可欣
Brand Name
Doptelet
Drug Type
化学药品
Dosage Form
片剂
Strength
20mg (按C29H34Cl2N6O3S2计)
Reg Date
2020-04-14
Expired Date
2025-04-13
Company Name
Akarx, Inc.
Company Address
3015 Carrington Mill Boulevard, Suite 410, Morrisville, NC 27560 United States of America
Production Company Name
kawashima plant, eisai co., ltd.
Production Company Address
1 Kawashimatakehaya-machi, Kakamigahara, Gifu 501-6024 JAPAN
Company Detail Path
/organization/akarx-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 14, 2020
Approval ID
7w10tmc2A32
Type
化学药品
Back to NMPA Approvals